Rodríguez-Baño, JesúsOteo, JesúsOrtega, AdrianaVillar, MacarenaConejo, María del CarmenBou, GermánAranzamendi-Zaldumbide, MaitaneCercenado, EmiliaGurgui, MercéMartínez-Martínez, LuisMerino, María CeciliaRivera, AlbaOliver, AntonioWeber, IrenePascual, ÁlvaroBartolomé, RosaGonzález-López, Juan JoséCampos, José2026-10-222026-10-222013-07-01Rodríguez-Baño J, Oteo J, Ortega A, Villar M, Conejo MC, Bou G, Aranzamendi-Zaldumbide M, Cercenado E, Gurguí M, Martínez-Martínez L, Merino M, Rivera A, Oliver A, Weber I, Pascual A, Bartolomé RM, Gónzalez-López JJ, Campos J. Epidemiological and clinical complexity of amoxicillin-clavulanate-resistant Escherichia coli. J Clin Microbiol. 2013 Jul;51(7):2414-7.1098-660Xhttps://hdl.handle.net/2183/49927Brief report[Abstract] Two hundred twelve patients with colonization/infection due to amoxicillin-clavulanate (AMC)-resistant Escherichia coli were studied. OXA-1- and inhibitor-resistant TEM (IRT)-producing strains were associated with urinary tract infections, while OXA-1 producers and chromosomal AmpC hyperproducers were associated with bacteremic infections. AMC resistance in E. coli is a complex phenomenon with heterogeneous clinical implications.engAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/Amoxicillin-Potassium Clavulanate CombinationAnti-Bacterial AgentsEscherichia coliEscherichia coli Infectionsbeta-Lactam ResistanceEpidemiological and Clinical Complexity of Amoxicillin-Clavulanate-Resistant Escherichia colijournal articleopen access10.1128/JCM.00999-13